Abstract
Stimulants are the recommended pharmacological treatment of choice for children and adolescents with ADHD, but there is no consensus in the field regarding the benefits and harms of methylphenidate. This Cochrane systematic review is an update of the first comprehensive systematic review on the topic conducted in 2015. The review is investigating the benefits and harms of methylphenidate treatment for children with ADHD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
